Virbac SA
PAR:VIRP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Virbac SA
PAR:VIRP
|
FR |
|
B
|
Branding Engineer Co Ltd
TSE:7352
|
JP |
|
CannaPharmaRx Inc
OTC:CPMD
|
CA |
|
Nihon Dempa Kogyo Co Ltd
TSE:6779
|
JP |
|
Takara & Company Ltd
TSE:7921
|
JP |
|
CBRE Group Inc
NYSE:CBRE
|
US |
|
China Citic Bank Corp Ltd
OTC:CHBJF
|
CN |
|
S
|
SG&G Corp
KOSDAQ:040610
|
KR |
|
C
|
Central African Gold Inc
OTC:NDENF
|
CA |
Wall Street
Price Targets
VIRP Price Targets Summary
Virbac SA
According to Wall Street analysts, the average 1-year price target for
VIRP
is 421.37 EUR
with a low forecast of 371.68 EUR and a high forecast of 462 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VIRP's stock price target?
Price Target
421.37
EUR
According to Wall Street analysts, the average 1-year price target for
VIRP
is 421.37 EUR
with a low forecast of 371.68 EUR and a high forecast of 462 EUR.
What is Virbac SA's Revenue forecast?
Projected CAGR
6%
For the last 14 years the
compound annual growth rate for
Virbac SA's revenue is
6%.
The projected
CAGR
for the next 3 years is
6%.
What is Virbac SA's Operating Income forecast?
Projected CAGR
10%
For the last 14 years the
compound annual growth rate for
Virbac SA's operating income is
7%.
The projected
CAGR
for the next 3 years is
10%.
What is Virbac SA's Net Income forecast?
Projected CAGR
13%
For the last 14 years the
compound annual growth rate for
Virbac SA's net income is
7%.
The projected
CAGR
for the next 3 years is
13%.
